Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1016/j.ejca.2023.02.018
dc.identifier.other
WOS:000992006000001
dc.description.volume
dc.description.issue
Publisher
ELSEVIER SCI LTD
DOI
10.1016/j.ejca.2023.02.018
Abstract
Description
Keywords
Metastatic hormone\\-sensitive prostate cancer \\(mHSPC\\) , Non metastatic castration\\-resistant prostate cancer \\(nmCRPC\\) , Metastatic castration\\-resistant prostate cancer \\(mCRPC\\) and oligometastatic and oligoprogressive prostate cancer , Hormonal treatment , Systemic therapy , Chemotherapy , Androgen receptor pathway inhibitors \\(ARPI\\) , Next\\-generation imaging , PSMA PET\\-imaging